Researchers have developed a new blood test that shows promise in detecting pancreatic cancer at earlier, more treatable stages. The test identifies a specific combination of protein biomarkers associated with the disease. In a study, it demonstrated high accuracy in distinguishing patients with pancreatic cancer from healthy individuals and those with non-cancerous pancreatic conditions. Early detection is critical for pancreatic cancer, which is often diagnosed too late for effective intervention. The test could become a valuable screening tool for high-risk populations if validated in larger trials. Read the full article at https://www.sciencedaily.com/releases/2026/03/260323005540.htm